Showing 1-3 of 3 results
Kevin Curran M.D.
Funded: 07-01-2012 through 06-30-2017
Funding Type: St. Baldrick's Scholar
Institution Location: New York, NY
Institution: Memorial Sloan Kettering Cancer Center

Based on progress to date, Dr. Curran, was awarded a new grant in 2016 to fund an additional year of this Scholar award. Our body can fight off infections using the immune system. This is why we feel better a few days after catching a cold. Our body can fight cancer in the same way, and the goal of Kevin Curran, M.D., AVM Traders St. Baldrick's Scholar's research is to teach the body to do that. This project aims to modify the immune system through gene therapy to create "cancer assassins" that target cancer cells. Ultimately, this method of cancer treatment may eliminate cancer without the side effects of current treatments such as chemotherapy (drugs) or radiation (x-rays). This grant is named for AVM Traders, a company that has raised more than $1 million for childhood cancer research through the St. Baldrick's Foundation.

Kevin Curran M.D.
Funded: 07-01-2010 through 06-30-2012
Funding Type: Research Grant
Institution Location: New York, NY
Institution: Memorial Sloan Kettering Cancer Center

The human body has an ability to detect and eliminate cancer through the immune system, but cancer cells can escape detection. Dr. Curran's research attempts to overcome this tumor escape via gene therapy mediated treatments. Pediatric leukemia is the most common childhood cancer, and patients with recurrent or resistant leukemia have limited options for treatment. Redirecting the immune system to eradicate resistant leukemia cells will provide a new possibility for a cure. Also, by specifically targeting cancer cells, we eliminate the long term complications associated with the conventional treatments of surgery, chemotherapy, and radiation. Dr. Curran was a St. Baldrick's Fellow and now has a faculty position.

Kevin Curran M.D.
Funded: 07-01-2009 through 06-30-2010
Funding Type: St. Baldrick's Fellow
Institution Location: New York, NY
Institution: Memorial Sloan Kettering Cancer Center

This new doctor is supported for training to specialize in pediatric oncology research, funded for 2 years or more.